DEC 01, 2021 3:26 PM PST

Researchers Use Ultrasound to Remove Diseased Brain Cells

WRITTEN BY: Annie Lennon

Researchers have developed a noninvasive method to remove faulty brain circuits using ultrasound and microbubbles. The corresponding research paper came from a collaboration of scientists at Stanford University and the University of Virginia School of Medicine and will be published in the Journal of Neurosurgery. 

At present, removing faulty brain cells either involves invasive surgery- physically removing the faulty brain cells in a surgical procedure or ablative surgery- inserting probes into the skin to destroy the affected region with heat (radiofrequency ablation), extreme cold (cryoablation), lasers or chemicals. 

Both of these procedures involve varying levels of risk. Risks following brain surgery may include temporary or prolonged impairment of memory, speech, and other cognitive functions. Ablative therapy on the brain has comparably fewer risks, although may narrow a person’s vision, cause bleeding in the brain and nerve damage. 

“This novel surgical strategy has the potential to supplant existing neurosurgical procedures used for the treatment of neurological disorders that don’t respond to medication,” said Kevin S. Lee, one of the study’s authors. “This unique approach eliminates the diseased brain cells, spares adjacent healthy cells and achieves these outcomes without even having to cut into the scalp.”

The new approach uses a combination of low-intensity focused ultrasound waves and microbubbles- biocompatible bubbles that are one-hundredth of a millimeter in diameter and work as ‘echo-enhancers’ for ultrasound treatments. These waves briefly penetrate the protective blood-brain barrier to deliver neurotoxins that destroy target brain cells while preserving healthy cells in the area. 

The approach, known as ‘PING’, has already shown success in lab experiments, having reduced or eliminated seizures in two research models of epilepsy. 

According to the researchers, PING enables a greater degree of precision than pre-existing treatments, which could allow specialists to reach irregularly shaped targets that could be difficult or impossible to reach otherwise. It would also allow clinicians to more specifically target problem cells, without affecting surrounding cells and tissue, unlike pre-existing treatments. 

“Our hope is that the PING strategy will become a key element in the next generation of very precise, noninvasive, neurosurgical approaches to treat major neurological disorders,” said Lee.

 

Sources: Neuroscience NewsUVA TodayEpilepsy.comMayo Clinic

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 18, 2021
Cannabis Sciences
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
NOV 18, 2021
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
According to the Centers for Disease Prevention and Control (CDC), antibiotic-resistant bacterial or fungal strains infe ...
NOV 30, 2021
Immunology
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
NOV 30, 2021
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
HIV is a master of disguise. Once the virus enters the body, it has a number of sophisticated mechanisms through which i ...
DEC 11, 2021
Health & Medicine
Third Dose of Pfizer-BioNTech Vaccine Could Reduce Effects of Omicron
DEC 11, 2021
Third Dose of Pfizer-BioNTech Vaccine Could Reduce Effects of Omicron
Many mainstream media sources are reporting on a new press release from Pfizer that suggests that a third dose of the Pf ...
DEC 16, 2021
Cancer
Age Matters! Young Adults May Need Different Cancer Therapies
DEC 16, 2021
Age Matters! Young Adults May Need Different Cancer Therapies
The incidence of various cancers, including multiple myeloma, colorectal, kidney, and pancreatic cancer, is steadily&nbs ...
DEC 29, 2021
Drug Discovery & Development
Drug discovery and development for treating river blindness
DEC 29, 2021
Drug discovery and development for treating river blindness
Onchocerciasis, also known as river blindness, is a parasitic disease caused by the filarial nematode Onchocerca vo ...
JAN 25, 2022
Genetics & Genomics
History of Creating Genetically Humanized Mice
JAN 25, 2022
History of Creating Genetically Humanized Mice
Animal research models are only as effective as their ability to simulate human disease.  Depending on the conditio ...
Loading Comments...